Last updated: 2026-09-13 06:48:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Palatin Technologies, Inc. (PTN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $11,75, with a market capitalization of $21,00M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $7,21 to $31,00. This page covers its latest market performance, valuation, price trends and company information.
$21,00M | |
$11,82 | |
$1 472,50 | |
$0,09 | |
$12,02 | |
19,97K | |
47,37K | |
-- | |
$31,00 | |
$7,21 | |
-- | |
-- |
Palatin Technologies, Inc. (PTN) last closed at $12,02 as of 2026-09-11 23:51:00, unchanged from the previous close of $12,02.
During the latest regular trading session, PTN traded between $0,09 and $1 472,50, with a volume of 19,97K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Palatin Technologies, Inc. (PTN) moved from $12,84 to $11,75, representing a decline of 8,49% ($1,09).
The stock traded between $11,29 and $14,00 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 189,92 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 19,1%
PTN is currently trading at $11,75, placing it 19,1% of the way from its 52-week low of $7,21 to its 52-week high of $31,00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 29 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Palatin Technologies, Inc. (PTN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.